Request Deal Involvement
LENZ Therapeutics completed the merger with Graphite Bio in a $225m deal.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
financial advisors
Leerink Partners
legal advisors
Goodwin Procter
financial advisors
Piper Sandler
financial advisors
William Blair & Co
legal advisors to financial advisors
Latham & Watkins
financial advisors
Bank of America
financial advisors
Citigroup
legal advisors
Wilson Sonsini Goodrich & Rosati
pr advisors
Precision AQ
or
Principals
vendor
ALPHA WAVE VENTURES
vendor
SECTORAL ASSET MANAGEMENT
target
GRAPHITE BIO
bidder
LENZ THERAPEUTICS
vendor
VERSANT VENTURES
vendor
RA CAPITAL MANAGEMENT
vendor
POINT72 VENTURES
vendor
SAMSARA BIOCAPITAL
vendor
RTW INVESTMENTS
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite